Thames Valley Cancer Network

Update in Lymphoma & Haematology TSSG Meeting

at:   Oxford Belfry Hotel

on:   Monday 20th June 2011

TO SEE THE AVAILABLE PRESENTATIONS, CLICK ON THE RELEVANT TALK

PROGRAMME

  9.00 - 9.30: Registration and tea/coffee

Session 1. Chairman: Dr Graham Collins (ORH, Oxford)
 
  9.30 - 10.00: Early trials in B-CLL: Are we ready for personalized medicine?
Dr Anna Schuh (ORH, Oxford)

10.00 - 10.45: Long-term cardiovascular effects of treatment for lymphoma
Dr David Cutter, Clinical Research Fellow, University of Oxford and
Specialist Registrar in Clinical Oncology (ORH, Oxford)

10.45: Coffee break

Session 2. Chairman: Dr Chris Hatton (ORH, Oxford)
 
11.15 - 11.35: Audit of high-dose therapy for patients with relapsed and transformed follicular lymphoma
Dr Leila Khalil and Dr Patrick Medd (ORH, Oxford)

11.35 - 12.05: Early phase trials in lymphoma - an update
Dr Graham Collins (ORH, Oxford)

12.05 - 12.25: Long-term follow up challenges - fertility guidelines
Dr Sylvia Benjamin (NHSBT, John Radcliffe Hospital, Oxford)

12.25 - 12.45: Audit of outcome of patients with Hodgkin lymphoma treated in Oxford
Dr Graham Collins (ORH, Oxford)

12.45:Lunch

  2.00Haematology TSSG meeting
 
Approval has been granted by the Royal College of Pathologists for a maximum of 3 CPD points.
 
Please feel free to contact Bridget Watson for further information.

We would like to thank the companies listed below for their sponsorship of this meeting:

       
       
     
       
Click on the logo above for a link to the company's web site.


Return to Home page